Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their informed consent to participate
- People aged 18 years or older
- People who have been clinically diagnosed with HLH (Hemophagocytic Lymphohistiocytosis — a serious condition where the immune system becomes dangerously overactive)
- People who have been receiving high-dose steroids and/or strong cancer-fighting treatments for less than 72 hours for their current episode of HLH (note: a medication called anakinra does not count as a cancer-fighting treatment for this purpose)
- People who have been taking steroids for more than 14 days before joining the trial may still be eligible (confirm with trial site)
- People who have had HLH before (recurring cases) may be eligible
- People who are already known to have lymphoma, or whose lymphoma has come back, may be eligible
Who may not be able to join:
- People whose HLH has already been confirmed to be caused by something other than cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of lymphoma-specific mutations in ctDNA from patients with lymphoma driven HLH.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.